Johnson & Johnson (NYSE:JNJ) saw a downside of -0.15% to close Monday at $160.26 after subtracting -$0.24 on the day. The 5-day average trading volume is 5,122,960 shares of the company’s common stock. It has gained $163.54 in the past week and touched a new high 2 times within the past 5 days. An average of 8,625,940 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 26,938,877.
JNJ’s 1-month performance is -2.93% or -$5.99 on its low of $157.35 reached on 09/06/23. The company’s shares have touched a 52-week low of $150.11 and high of $181.04, with the stock’s rally to the 52-week high happening on 01/06/23. YTD, JNJ has lost -9.28% or -$16.39 and has reached a new high 3 times. However, the current price is down -11.48% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
JNJ stock investors last saw insider trading activity on Jul 26.Hait William () most recently sold 14,698 shares at $172.00 per share on Jul 26. This transaction cost the insider $2,528,056. Exec VP, Chief HR Officer, Fasolo Peter, sold 20,000 shares at a price of $170.32 on Jul 25. Then, on Jun 12, EVP, Chief TO and Risk Officer Wengel Kathryn E sold 12,465 shares at a price of $160.00 per share. This transaction amounted to $1,994,400.
Valuation Metrics
JNJ stock has a beta of 0.54. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 3.95 while the price-to-book (PB) in the most recent quarter is 5.54, with the price to cash flow ratio at 26.53.
Johnson & Johnson’s quick ratio for the period ended June 29 was 0.88, with the current ratio over the same period at 1.12. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.45, while the total debt to equity was 0.61. In terms of profitability, the gross margin trailing 12 months is 67.59%. The trailing 12-month EBITDA margin is 33.42% while for the period ending June 29, Johnson & Johnson’s operating margin was 26.37%. The firm’s gross profit as reported stood at $63.85 billion against revenue of $94.94 billion.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 6.42% to $5.14 billion, while revenue of -$68.0 million was 101.32% off the previous quarter. Analysts expected JNJ to announce $2.62 per share in earnings in its latest quarter, but it posted $2.56, representing a -2.30% surprise. EBITDA for the quarter stood at more than $9.41 billion. JNJ stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 115.28 billion, with total debt at $45.6 billion. Shareholders hold equity totaling $2.6 billion.
Let’s look briefly at Johnson & Johnson (JNJ) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 25 September was 36.55% to suggest the stock is trending Neutral, with historical volatility in this time period at 12.77%.
The stock’s 5-day moving average is $161.51, reflecting a -1.36% or -$2.21 change from its current price. JNJ is currently trading -3.60% above its 20-day SMA, -2.89% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +0.24% and SMA200 by-8.99%.
Stochastic %K and %D was 43.64% and 53.02% and the average true range (ATR) pointed at 2.19. The RSI (14) points at 39.27%, while the 14-day stochastic is at 36.74% with the period’s ATR at 2.38. The stock’s 9-day MACD Oscillator is pointing at -1.32 and -0.91 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Johnson & Johnson (NYSE: JNJ), HSBC Securities launched coverage with a Hold rating. Analysts offering their rating for JNJ stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate JNJ as a “sell,”, while 14 advise that investors “Hold.” 1 analysts have rated the stock as underweight. 2 rates the stock as overweight while 6 have offered a “buy” rating.
What is JNJ’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $158.00 and a high of $215.00, with their median price target at $180.00. Looking at these predictions, the average price target given by analysts is for Johnson & Johnson (JNJ) stock is $180.26.
